Generic Name and Formulations:
Clindamycin (as phosphate) 1%; foam; contains alcohol.
Indications for EVOCLIN:
Wash and dry skin. Apply once daily. Dispense an amount that will cover the affected area(s) into cap or other cool surface. Pick up a small amount of foam with fingertips and massage into affected area(s) until foam disappears.
History of regional enteritis, ulcerative or antibiotic-associated colitis (including pseudomembranous colitis).
Atopic patients. Discontinue if significant diarrhea, irritation, or dermatitis occurs. Avoid contact with eyes, mouth, lips, other mucous membranes or broken skin. Discontinue if no improvement after 6–8 weeks or if condition worsens. Product is flammable. Pregnancy (Cat.B). Nursing mothers: not recommended.
May potentiate neuromuscular blockers. Cross-resistance may occur with erythromycin. Prolonged and/or worsened severe colitis with antiperistaltic agents (eg, opiates, diphenoxylate with atropine).
Application site reactions (eg, burning, pruritus, dryness), headache, irritation, gram (–) folliculitis, abdominal pain, Gl disturbances; rare: diarrhea, pseudomembranous colitis.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Undifferentiated Headaches Common in Children, Adolescents
- Smoking Associated With Increased Relapse Rate in Interferon Beta-Treated Relapsing-Remitting MS
- Frontotemporal Dementia, Frontotemporal Lobar Degeneration Symptoms More Common Later in Life
- No Reduction in Cerebral Perfusion With Intensive Blood Pressure Lowering
- Successful Delirium Prevention in Critically Ill With Dexmedetomidine